165 related articles for article (PubMed ID: 10049261)
1. Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats.
LeBrun M; Grenier L; Bergeron MG; Thibault L; Labrecque G; Beauchamp D
Antimicrob Agents Chemother; 1999 Mar; 43(3):520-4. PubMed ID: 10049261
[TBL] [Abstract][Full Text] [Related]
2. Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats.
Beauchamp D; Collin P; Grenier L; LeBrun M; Couture M; Thibault L; Labrecque G; Bergeron MG
Antimicrob Agents Chemother; 1996 Mar; 40(3):670-6. PubMed ID: 8851591
[TBL] [Abstract][Full Text] [Related]
3. Day-night treatment difference of tobramycin serum and intrarenal drug distribution and nephrotoxicity in rats: effects of fasting.
Lin L; Grenier L; LeBrun M; Bergeron MG; Thibault L; Labrecque G; Beauchamp D
Chronobiol Int; 1996 Jul; 13(2):113-21. PubMed ID: 8877120
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of amphotericin B in rats: effects of the time of administration.
LeBrun M; Grenier L; Gourde P; Bergeron MG; Labrecque G; Beauchamp D
Life Sci; 1996; 58(11):869-76. PubMed ID: 8786692
[TBL] [Abstract][Full Text] [Related]
5. Enzymuria following amphotericin B application in the rat.
Inselmann G; Balaschke M; Heidemann HT
Mycoses; 2003 Jun; 46(5-6):169-73. PubMed ID: 12801357
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic effects of flucytosine on amphotericin B nephrotoxicity in rats.
Heidemann HT; Brune KH; Sabra R; Branch RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2670-5. PubMed ID: 1482135
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B.
Hossain MA; Maesaki S; Razzaque MS; Tomono K; Taguchi T; Kohno S
J Antimicrob Chemother; 2000 Aug; 46(2):263-8. PubMed ID: 10933650
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats.
Lin L; Grenier L; Bergeron Y; Simard M; Bergeron MG; Labrecque G; Beauchamp D
Antimicrob Agents Chemother; 1994 Jan; 38(1):54-60. PubMed ID: 8141580
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of oxidative stress in D-serine induced nephrotoxicity.
Orozco-Ibarra M; Medina-Campos ON; Sánchez-González DJ; Martínez-Martínez CM; Floriano-Sánchez E; Santamaría A; Ramirez V; Bobadilla NA; Pedraza-Chaverri J
Toxicology; 2007 Jan; 229(1-2):123-35. PubMed ID: 17110013
[TBL] [Abstract][Full Text] [Related]
10. Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats.
Bekersky I; Boswell GW; Hiles R; Fielding RM; Buell D; Walsh TJ
Pharm Res; 2000 Dec; 17(12):1494-502. PubMed ID: 11303959
[TBL] [Abstract][Full Text] [Related]
11. Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
Sabra R; Zeinoun N; Sharaf LH; Ghali R; Beshara G; Serhal H
Pharmacol Toxicol; 2001 Apr; 88(4):168-75. PubMed ID: 11322173
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.
Wasan KM; Kennedy AL; Cassidy SM; Ramaswamy M; Holtorf L; Chou JW; Pritchard PH
Antimicrob Agents Chemother; 1998 Dec; 42(12):3146-52. PubMed ID: 9835506
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice.
Tonomura Y; Yamamoto E; Kondo C; Itoh A; Tsuchiya N; Uehara T; Baba T
Hum Exp Toxicol; 2009 May; 28(5):293-300. PubMed ID: 19661263
[TBL] [Abstract][Full Text] [Related]
15. Effect of an adenosine receptor antagonist on acute amphotericin B nephrotoxicity.
Kuan CJ; Branch RA; Jackson EK
Eur J Pharmacol; 1990 Mar; 178(3):285-91. PubMed ID: 2340862
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome C suppresses renal accumulation and nephrotoxicity of polymyxin B.
Li ZD; Luo J; Jia LH; Wang XY; Xun ZK; Liu M
Hum Exp Toxicol; 2019 Feb; 38(2):193-200. PubMed ID: 30016892
[TBL] [Abstract][Full Text] [Related]
17. Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.
Risovic V; Boyd M; Choo E; Wasan KM
Antimicrob Agents Chemother; 2003 Oct; 47(10):3339-42. PubMed ID: 14506053
[TBL] [Abstract][Full Text] [Related]
18. Sodium status influences chronic amphotericin B nephrotoxicity in rats.
Ohnishi A; Ohnishi T; Stevenhead W; Robinson RD; Glick A; O'Day DM; Sabra R; Jackson EK; Branch RA
Antimicrob Agents Chemother; 1989 Aug; 33(8):1222-7. PubMed ID: 2802551
[TBL] [Abstract][Full Text] [Related]
19. Influence of diet on experimental toxicity of amphotericin B deoxycholate.
Chavanet P; Joly V; Rigaud D; Bolard J; Carbon C; Yeni P
Antimicrob Agents Chemother; 1994 May; 38(5):963-8. PubMed ID: 8067777
[TBL] [Abstract][Full Text] [Related]
20. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.
Bulacio RP; Torres AM
Arch Toxicol; 2013 Nov; 87(11):1953-1962. PubMed ID: 23649842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
